Literature DB >> 27037892

Edible plants for oral delivery of biopharmaceuticals.

Matilde Merlin1, Mario Pezzotti1, Linda Avesani1.   

Abstract

Molecular farming is the use of plants for the production of high value recombinant proteins. Over the last 25 years, molecular farming has achieved the inexpensive, scalable and safe production of pharmaceutical proteins using a range of strategies. One of the most promising approaches is the use of edible plant organs expressing biopharmaceuticals for direct oral delivery. This approach has proven to be efficacious in several clinical vaccination and tolerance induction trials as well as multiple preclinical studies for disease prevention. The production of oral biopharmaceuticals in edible plant tissues could revolutionize the pharmaceutical industry by reducing the cost of production systems based on fermentation, and also eliminating expensive downstream purification, cold storage and transportation costs. This review considers the unique features that make plants ideal as platforms for the oral delivery of protein-based therapeutics and describes recent developments in the production of plant derived biopharmaceuticals for oral administration.
© 2016 The British Pharmacological Society.

Keywords:  edible plant; molecular farming; oral delivery; oral tolerance; transgenic plants; vaccine

Mesh:

Substances:

Year:  2016        PMID: 27037892      PMCID: PMC5338148          DOI: 10.1111/bcp.12949

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  79 in total

Review 1.  Novel human polysaccharide adjuvants with dual Th1 and Th2 potentiating activity.

Authors:  Nikolai Petrovsky
Journal:  Vaccine       Date:  2006-04-12       Impact factor: 3.641

2.  Study of the immunogenicity of hepatitis B surface antigen synthesized in transgenic potato plants with increased biosafety.

Authors:  Elena B Rukavtsova; Natalya V Rudenko; Elena N Puchko; Natalya S Zakharchenko; Yaroslav I Buryanov
Journal:  J Biotechnol       Date:  2015-03-31       Impact factor: 3.307

3.  The fusion of Toxoplasma gondii SAG1 vaccine candidate to Leishmania infantum heat shock protein 83-kDa improves expression levels in tobacco chloroplasts.

Authors:  Romina M Albarracín; Melina Laguía Becher; Inmaculada Farran; Valeria A Sander; Mariana G Corigliano; María L Yácono; Sebastián Pariani; Edwin Sánchez López; Jon Veramendi; Marina Clemente
Journal:  Biotechnol J       Date:  2015-04-22       Impact factor: 4.677

Review 4.  Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells.

Authors:  Kwang-Chul Kwon; Dheeraj Verma; Nameirakpam D Singh; Roland Herzog; Henry Daniell
Journal:  Adv Drug Deliv Rev       Date:  2012-10-23       Impact factor: 15.470

5.  Low-cost oral delivery of protein drugs bioencapsulated in plant cells.

Authors:  Kwang-Chul Kwon; Henry Daniell
Journal:  Plant Biotechnol J       Date:  2015-09-03       Impact factor: 9.803

6.  Low cost industrial production of coagulation factor IX bioencapsulated in lettuce cells for oral tolerance induction in hemophilia B.

Authors:  Jin Su; Liqing Zhu; Alexandra Sherman; Xiaomei Wang; Shina Lin; Aditya Kamesh; Joey H Norikane; Stephen J Streatfield; Roland W Herzog; Henry Daniell
Journal:  Biomaterials       Date:  2015-08-05       Impact factor: 12.479

Review 7.  Mechanism of oral tolerance induction to therapeutic proteins.

Authors:  Xiaomei Wang; Alexandra Sherman; Gongxian Liao; Kam W Leong; Henry Daniell; Cox Terhorst; Roland W Herzog
Journal:  Adv Drug Deliv Rev       Date:  2012-11-02       Impact factor: 15.470

8.  Oral immunogenicity of porcine reproductive and respiratory syndrome virus antigen expressed in transgenic banana.

Authors:  Hui-Ting Chan; Min-Yuan Chia; Victor Fei Pang; Chian-Ren Jeng; Yi-Yin Do; Pung-Ling Huang
Journal:  Plant Biotechnol J       Date:  2012-11-01       Impact factor: 9.803

9.  Good manufacturing practices production of a purification-free oral cholera vaccine expressed in transgenic rice plants.

Authors:  Koji Kashima; Yoshikazu Yuki; Mio Mejima; Shiho Kurokawa; Yuji Suzuki; Satomi Minakawa; Natsumi Takeyama; Yoshiko Fukuyama; Tatsuhiko Azegami; Takeshi Tanimoto; Masaharu Kuroda; Minoru Tamura; Yasuyuki Gomi; Hiroshi Kiyono
Journal:  Plant Cell Rep       Date:  2015-12-11       Impact factor: 4.570

10.  Transgenic tobacco expressed HPV16-L1 and LT-B combined immunization induces strong mucosal and systemic immune responses in mice.

Authors:  Liu Hongli; Li Xukui; Lei Ting; Li Wensheng; Si Lusheng; Zheng Jin
Journal:  Hum Vaccin Immunother       Date:  2012-10-29       Impact factor: 3.452

View more
  9 in total

1.  Are nutraceuticals the modern panacea? From myth to science.

Authors:  Pietro Minuz; Giampaolo Velo; Francesco Violi; Albert Ferro
Journal:  Br J Clin Pharmacol       Date:  2017-01       Impact factor: 4.335

Review 2.  Edible plants for oral delivery of biopharmaceuticals.

Authors:  Matilde Merlin; Mario Pezzotti; Linda Avesani
Journal:  Br J Clin Pharmacol       Date:  2016-05-09       Impact factor: 4.335

Review 3.  Plant-made vaccines and reagents for the One Health initiative.

Authors:  Edward Peter Rybicki
Journal:  Hum Vaccin Immunother       Date:  2017-08-28       Impact factor: 3.452

Review 4.  Disease Prevention: An Opportunity to Expand Edible Plant-Based Vaccines?

Authors:  Christopher Concha; Raúl Cañas; Johan Macuer; María José Torres; Andrés A Herrada; Fabiola Jamett; Cristian Ibáñez
Journal:  Vaccines (Basel)       Date:  2017-05-30

5.  Design of a Type-1 Diabetes Vaccine Candidate Using Edible Plants Expressing a Major Autoantigen.

Authors:  Edoardo Bertini; Matilde Merlin; Elisa Gecchele; Andrea Puggia; Annalisa Brozzetti; Mauro Commisso; Alberto Falorni; Vittorio Bini; Victor Klymyuk; Mario Pezzotti; Linda Avesani
Journal:  Front Plant Sci       Date:  2018-05-01       Impact factor: 5.753

6.  Bioengineering horizon scan 2020.

Authors:  Luke Kemp; Laura Adam; Christian R Boehm; Rainer Breitling; Rocco Casagrande; Malcolm Dando; Appolinaire Djikeng; Nicholas G Evans; Richard Hammond; Kelly Hills; Lauren A Holt; Todd Kuiken; Alemka Markotić; Piers Millett; Johnathan A Napier; Cassidy Nelson; Seán S ÓhÉigeartaigh; Anne Osbourn; Megan Palmer; Nicola J Patron; Edward Perello; Wibool Piyawattanametha; Vanessa Restrepo-Schild; Clarissa Rios-Rojas; Catherine Rhodes; Anna Roessing; Deborah Scott; Philip Shapira; Christopher Simuntala; Robert Dj Smith; Lalitha S Sundaram; Eriko Takano; Gwyn Uttmark; Bonnie Wintle; Nadia B Zahra; William J Sutherland
Journal:  Elife       Date:  2020-05-29       Impact factor: 8.713

7.  Plant-made E2 glycoprotein single-dose vaccine protects pigs against classical swine fever.

Authors:  Richard C Laughlin; Rachel Madera; Yair Peres; Brian R Berquist; Lihua Wang; Sterling Buist; Yulia Burakova; Sreenath Palle; Chungwon J Chung; Max V Rasmussen; Erica Martel; David A Brake; John G Neilan; Sara D Lawhon; L Garry Adams; Jishu Shi; Sylvain Marcel
Journal:  Plant Biotechnol J       Date:  2018-08-10       Impact factor: 9.803

8.  Parenteral-Oral Immunization with Plant-Derived HBcAg as a Potential Therapeutic Vaccine against Chronic Hepatitis B.

Authors:  Marcin Pyrski; Adam Aron Mieloch; Adam Plewiński; Aneta Basińska-Barczak; Aleksandra Gryciuk; Piotr Bociąg; Marek Murias; Jakub Dalibor Rybka; Tomasz Pniewski
Journal:  Vaccines (Basel)       Date:  2019-12-09

9.  Plant-derived protein bodies as delivery vehicles for recombinant proteins into mammalian cells.

Authors:  Jennifer Schwestka; Marc Tschofen; Stefan Vogt; Sylvain Marcel; Johannes Grillari; Marianne Raith; Ines Swoboda; Eva Stoger
Journal:  Biotechnol Bioeng       Date:  2020-01-30       Impact factor: 4.395

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.